Trials of a Covid-19 vaccine being developed by AstraZeneca and Oxford University will resume after a pause due to a reported side effect in a patient in the UK.
AstraZeneca issued a statement on Tuesday night saying the late-stage studies of the vaccine had been paused while the company investigated whether the patient’s reported side effect is connected with the vaccine.
On Saturday, Oxford University confirmed that trials would resume across all UK clinical trial sites.
It comes after the Government’s chief scientific adviser Sir Patrick Vallance told a Downing Street press conference what has happened in the Oxford trial is not unusual.
He added that similar events should also be expected in some of the other vaccine candidate trials.
News site Stat first reported the pause in testing and said the possible side effect occurred in a testing volunteer in Britain, who was expected to recover.
The vaccine is being tested in thousands of people in Britain and the US, and in smaller study groups in Brazil and South America.
Discover more from London Glossy Post
Subscribe to get the latest posts sent to your email.
